Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH campaign promotes responsible medicine use
NOAH is encouraging practices to display their poster, and engage with the campaign using #Paws2Protect.
‘Paws to Protect’ encourages pet owners to follow medicine directions carefully.

The National Office for Animal Health (NOAH) has begun a campaign to promote the responsible use of veterinary medicines by pet owners.

The ‘Paws to Protect’ campaign provides advice and information for pet owners, urging them to carefully read and understand the information that is on their pet’s medication.

As well as producing a downloadable poster that veterinary practices are being encouraged to display, the trade association has published information on their website to better educate users.

The campaign explains the importance of the correct use of pet medication to owners, detailing the effect that irresponsible use can have on them, their pet and the environment. It also describes how it relates to regulatory controls, and the continued efficacy of the medicine.

The guidance advises users on what information they should look for on the leaflets, packaging or labels of their medication. It explains the meanings and purposes of such details, including the dosage, administration, warnings and target species.

NOAH is asking veterinary practices to join their campaign by downloading and displaying their poster, as well as engaging with the campaign using its hashtag #Paws2Protect.

The campaign has been launched in response to a survey conducted by NOAH which revealed that, although 78 per cent of pet owners were aware of and followed instructions on their pet’s medication, 16-34 year olds were least likely to adhere to the directions. With 16-34 year olds making up approximately two thirds of new pet owners, the organisation felt that more needed to be done to promote the cause.

NOAH chief executive Dawn Howard said: “This highlights a gap in understanding about the need to always use veterinary medicines appropriately.

“It risks the medicine not working properly, resulting in implications to animal health and welfare and could even mean specific advice and instructions are ignored that could harm the animal, the person giving the medicine or the environment.

“To reach this group, we are reaching out on our social media using #Paws2Protect, and we need help from those that prescribe and sell veterinary medicines to help us spread the word. We hope our new resources will provide them with additional support to ensure this important message is understood.”

The resources can be accessed here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.